Achilles therapeutics to present at the 32nd annual oppenheimer healthcare conference

London, march 08, 2022 (globe newswire) -- achilles therapeutics plc (nasdaq: achl), a clinical-stage biopharmaceutical company developing precision t cell therapies to treat solid tumors, today announced its participation in the 32nd annual oppenheimer healthcare conference taking place virtually march 15 - 17, 2022. iraj ali, chief executive officer, will present an overview of the company and pipeline on tuesday, march 15, 2022, at 8:00 am et / 12:00 pm uk.
ACHL Ratings Summary
ACHL Quant Ranking